West Pharmaceutical Services Stock News

In the latest trading session, West Pharmaceutical Services (WST) closed at $400.69, marking a -0.01% move from the previous day.

The womens Hundred cricket tournament and Womens Super League soccer brought in nearly 11 million new viewers as womens sport attracted record viewing figures in Britain in 2021, the Womens Sport Trust (WST) said on Tuesday. The trusts Visibility Uncovered study found that almost 33 million people tuned in to womens sport last year, with []

EXTON, Pa., Feb. 3, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will relea

Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) -- The global sterile medical packaging market size is expected to reach USD 68.49 billion by 2028, exhibiting a CAGR of 8.1% during the forecast period. The growing cognizance about the advantageous properties of sterile medical packaging such as tear resistance, durability, breathability, and the superior microbial barrier will promote the growth of the market during the forecast period. The market size stood at USD 35.74 Billion in 2020. The escalating requirements for sterile medical packaging in numerous applications, involving in-vitro diagnostic products and surgical & medical instruments will have a positive impact on the market in the forthcoming years. The Report Lists the Key Companies in the Sterile Medical Packaging Market: Amcor Plc (Switzerland) Placon (U.S.) DuPont (U.S.) Steripack Ltd. (Ireland) Wipak Group (Finland) Nelipak Healthcare (U.S.) Tekni-Plex(U.S.) Sonoco (U.S.) BillerudKorsnäs AB (Sweden) ProAmpac (U.S.) West Pharmaceutical Services, Inc. (U.S.) Riverside Medical Packaging Company Ltd (UK) Oliver Healthcare Packaging (U.S.) GS Medical Packaging (Canada) Orchid (U.S.) Techinipaq Inc. (U.S.) Others Get a Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/sterile-medical-packaging-market-102798 Market Driver : Growing Hygiene and Sterility in Medical Equipment to Stimulate Growth The increasing prevalence of infectious and communicable diseases and viruses such as COVID-19, flu, tuberculosis, and SARS has led to improved hygiene in medical devices intending to prevent any contamination or spread of disease in patients.

West Pharmaceutical (WST) continues to gain momentum on the back of strength in the Proprietary Products business. However, forex woes persist.

In the latest trading session, West Pharmaceutical Services (WST) closed at $393.22, marking a +0.05% move from the previous day.

West Pharmaceutical Services (WST) announced an exclusive supply and technology pact with Corning Incorporated (GLW)

I present my top 15 high-growth dividend stocks to consider during the month of January. Last month's list returned 4.65% in December to finish out 2021 with a total return of 33.52%.

West Pharmaceutical Services Inc. stock underperforms Friday when compared to competitors MarketWatch

West Pharmaceutical (WST) declares $0.18/share quarterly dividend, in line with previous.

EXTON, Pa., Jan. 5, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc.

There are 23 stocks on my dividend growth watchlist for January 2022. Six of the stocks on my watchlist are currently undervalued based on dividend yield theory.

West Pharmaceutical Services, Inc. (WST) shares closed today at 1.3% below its 52 week high of $475.14, giving the company a market cap of $34B. The stock is currently up 66.6% year-to-date, up 68.6% over the past 12 months, and up 466.3% over the past five years. This week, the Dow Jones Industrial Average rose 1.3%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 53.2% lower than the 20-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.8. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , beats it on a 1-year basis, and beats it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , beats it on a 1-year basis, and beats it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 5274.5% The company's stock price performance over the past 12 months beats the peer average by 3450.7% The company's price-to-earnings ratio, which relates a company's share price to its earnings per share, is 79.1% higher than the average peer. This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.